AKT1 and breast carcinoma: A recent pioneer study reported that fisetin induced the apoptosis of breast cancer cells by numerous mechanisms, including the induction of proteasomal degradation, decreasing its half-life, the inactivation of the receptor, decreasing enolase phosphorylation, as well as the alteration of PI3 kinase/AKT signaling [121].